The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing

The only licensed vaccine against tuberculosis (TB), bacille Calmette–Guérin (BCG), protects against severe extrapulmonary forms of TB but is virtually ineffective against the most prevalent form of the disease, pulmonary TB. BCG was genetically modified at the Max Planck Institute for Infection Bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieuwenhuizen, Natalie E., Kulkarni, Prasad S., Shaligram, Umesh, Cotton, Mark F., Rentsch, Cyrill A., Eisele, Bernd, Grode, Leander, Kaufmann, Stefan H. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610719/
https://www.ncbi.nlm.nih.gov/pubmed/28974949
http://dx.doi.org/10.3389/fimmu.2017.01147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610719/
https://www.ncbi.nlm.nih.gov/pubmed/28974949
http://dx.doi.org/10.3389/fimmu.2017.01147

Ejemplares similares